Monitor the upcoming annual meeting vote outcome for board control. The heavily pro-management analyst consensus (88% bullish) and the dissident's small 0.7% stake suggest management slate is favored, but the activist escalation via cross-filings (amplifier verdicts) keeps uncertainty elevated. Stock may remain range-bound until the vote is certified.
Price Chart
Executive Summary
Vaxart has filed definitive additional proxy soliciting materials (DEFA14A) urging shareholders to vote FOR all six of the board's director nominees and WITHHOLD on the three nominees proposed by dissident stockholder Daniel P. Houle. The filing is a social media campaign reinforcing management's stance in the ongoing contested director election for the 2026 annual meeting.
Key Facts
- Contested director election: management slate of 6 nominees vs. dissident slate of 3 nominees from Daniel P. Houle
- Board unanimously recommends voting FOR all six management nominees on the WHITE proxy card
- Dissident nominees characterized as lacking relevant biotech experience with ~0.7% ownership stake per prior filing
- This is definitive additional soliciting material (DEFA14A), escalating from the preliminary PREC14A filed 20 days ago
Financial Impact
No financial figures in filing; impact depends on proxy contest outcome. If dissident slate prevails, potential board composition change and strategy shift.
Risk Factors
- Dissident slate could win board seats if retail shareholders break for Houle's nominees
- Protracted proxy contest could distract management from vaccine development milestones
- Vaxart is a clinical-stage biotech with no approved products; governance uncertainty adds overhang
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-066368 |
| Document: 0001213900-26-066368-index-headers.html | 0001213900-26-066368 |
| Document: 0001213900-26-066368-index.html | 0001213900-26-066368 |
| Document: 0001213900-26-066368.txt | 0001213900-26-066368 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 28, 2026 9w ago | 8-K | $0.4800 $0.5000 | ▲ +4.17% | ▲ +0.79% | $0.4301 (−10.40%) |
Jul 7, 2026 12w ago | 8-K | $0.5500 $0.6000 | ▲ +9.09% | ▲ +5.93% | $0.4301 (−21.80%) |
Jul 6, 2026 12w ago | DEFA14A | $0.6200 $0.5900 | ▼ −4.84% | ▼ −5.69% | $0.4301 (−30.63%) |
Jul 2, 2026 13w ago | DEFA14A | $0.6400 $0.5490 | ▼ −14.22% | ▼ −14.52% | $0.4301 (−32.80%) |
Jul 2, 2026 13w ago | 8-K | $0.6400 $0.5200 | ▼ −18.75% | ▼ −18.34% | $0.4301 (−32.80%) |
Jun 26, 2026 13w ago | DEFA14A | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4301 (−24.54%) |
Jun 26, 2026 13w ago | DEFA14A | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4301 (−24.54%) |
Jun 26, 2026 13w ago | 8-K | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4301 (−24.54%) |
Jun 16, 2026 15w ago | DEFA14A | $0.5600 $0.5300 | ▼ −5.36% | ▼ −6.21% | $0.4301 (−23.20%) |
Jun 8, 2026 16w ago | DEFA14A | $0.5800 $0.5502 | ▼ −5.14% | ▼ −6.53% | $0.4301 (−25.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access